79 related articles for article (PubMed ID: 14965550)
1. Nationwide breast cancer screening programme fully implemented in The Netherlands.
Fracheboud J; de Koning HJ; Boer R; Groenewoud JH; Verbeek AL; Broeders MJ; van Ineveld BM; Hendriks JH; de Bruyn AE; Holland R; van der Maas PJ;
Breast; 2001 Feb; 10(1):6-11. PubMed ID: 14965550
[TBL] [Abstract][Full Text] [Related]
2. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
3. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
4. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
Zackrisson S; Janzon L; Manjer J; Andersson I
J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
[TBL] [Abstract][Full Text] [Related]
5. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
6. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
7. Screening for breast cancer in England: past and future.
Advisory Committee on Breast Cancer Screening
J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
Richardson A; Graham P; Brown T; Smale P; Cox B
J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of screen-detected breast cancers: results of a population based study.
Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
[TBL] [Abstract][Full Text] [Related]
10. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
11. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
12. [Breast self-examination also valuable in women participating in a screening programme].
Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP
Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066
[TBL] [Abstract][Full Text] [Related]
13. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
Yeoh KG; Chew L; Wang SC
J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer incidence after the introduction of mammography screening: what should be expected?
Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer screening programme in The Netherlands: an interim review.
van der Maas PJ
Breast; 2001 Feb; 10(1):12-4. PubMed ID: 14965551
[TBL] [Abstract][Full Text] [Related]
17. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
18. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
19. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
Bordás P; Jonsson H; Nyström L; Lenner P
J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic women with normal screening mammograms: is assessment by the breast screening programme justifiable?
Litherland JC; Dobson HM
Breast; 2001 Feb; 10(1):58-60. PubMed ID: 14965562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]